With the rise of GLP-1 medications like Semaglutide (Ozempic) and Tirzepatide (Mounjaro), there has been a lot of misinformation circulating. Let’s clear up some of the most common myths about these medications.
Myth 1: GLP-1 Medications Are Only for People with Diabetes
While Semaglutide was originally developed to manage type 2 diabetes, it has since been FDA-approved for weight loss in individuals without diabetes as well. Research shows that non-diabetic patients can benefit from GLP-1 medications by reducing their appetite and achieving significant weight loss.
Myth 2: GLP-1 Medications Cause Dangerous Side Effects
All medications carry potential side effects, but for most patients, the side effects of GLP-1 medications are mild and temporary. Side effects like nausea and digestive discomfort typically subside within the first few weeks of treatment. Additionally, working with a healthcare provider ensures that any side effects are closely monitored and managed with proper dosage adjustments.
Myth 3: Weight Loss from GLP-1 Medications Isn’t Sustainable
Some people worry that they’ll regain the weight once they stop taking Semaglutide or Tirzepatide. The truth is that, when combined with lifestyle changes such as healthy eating and regular physical activity, GLP-1 medications help patients establish new habits that make long-term weight management achievable. These medications offer a jump-start to weight loss, and the skills you build while taking them help maintain your results.
Fact: GLP-1 Medications Can Be Customized
One advantage of working with a board-certified plastic surgeon is the availability of compounded GLP-1 medications. These versions allow for customized dosing that fits your specific needs, providing a more flexible and personalized approach to weight loss.
